Companies: 10,795·Total market cap: $144.5T
Haleon plc

Haleon plc

HLNNYSEHealthcare● Active
$8.91
$-0.22(-2.36%)
Market Cap$39.5B
P/E Ratio
52W High$11.28
52W Low$8.65

Haleon plc(HLN)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

hln · 股价预测 · 4 位分析师(近3月)· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 4 位华尔街分析师

SellBuy

Buy

4 位分析师

共识

评级分布

Strong Buy
0
Buy
3
Hold
1
Sell
0
Strong Sell
0
合计: 4 · 买入占比: 75.0%

12 个月目标价

High

$10.20

Consensus

$10.20

+13.6% upside

Low

$10.20

Median: $10.2 · Last Close: $8.98

Haleon plc(HLN)的分析师共识为 Buy,基于过去 3 个月内 4 位华尔街分析师的评级。HLN 的 12 个月平均目标价为 $10.20,相对当前价 $8.98 代表 +13.6% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足,无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-09$8.871.26%

1-day model range: $8.84–$8.89. Peak: $8.89 (-1.26%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$10+6.9%
2028$10+11.7%
2029$10+15.0%
2030$11+17.1%
2031+18.6%
Confidence:Medium

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

14%7%79%
2Buy
1Neutral
11Sell
RSI (14)43.6Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · HLN · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$8.90BUY
MA 10$9.02SELL
MA 20$9.07SELL
MA 50$9.40SELL
MA 100$9.95SELL
MA 200$9.74SELL
Current $HLN · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$8.98BUY
EMA 10$9.01SELL
EMA 20$9.09SELL
EMA 50$9.37SELL
EMA 100$9.63SELL
EMA 200$9.76SELL
Current $HLN · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
Barclays2026-01-23
Upgrade ↑
Equal WeightOverweight
Barclays2025-09-16
Downgrade ↓
OverweightEqual Weight
Morgan Stanley2024-09-20
Maintains
OverweightOverweight
Argus Research2024-03-26
Maintains
BuyBuy
Argus Research2023-04-06
Upgrade ↑
HoldBuy
Argus Research2022-09-28
Maintains
HoldHold
Deutsche Bank2022-07-29
Maintains
HoldHold

Wall Street analysts have recently issued updated ratings on Haleon plc (HLN) stock. Of the recent 7 rating actions, 2 were upgrades and 1 were downgrades. 4 analysts currently cover HLN.

分析师推荐趋势

Buy ratings01↑ +1
Hold ratings101
Sell ratings00

HLN analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$11.7B

↓ 8.0% YoY

Revenue Next Year

$12.2B

↑ 4.2% YoY

EPS This Year

$0.42

EPS Next Year

$0.46

↑ 9.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast HLN EPS of $0.42 for the current fiscal year, based on estimates from 5 analysts. The HLN revenue forecast is $11.7B for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

HLN 股价预测由两类独立数据源支撑:来自 4 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。HLN 的共识目标价为 $10.20(+13.6% 上行空间),分析师共识为 Buy。

HLN 的短期预测(明日)为 $8.87(-1.26%)。 HLN 对 2027 年的股价预测均值为 $10。 HLN 对 2030 年的预测区间为 $10–$11。

Haleon plc 在 NYSE 上市,代码 HLN。HLN 在 2027 年的整体展望偏积极,在覆盖分析师中约 75% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

HLN 预测 · 8 个问题

根据 4 位华尔街分析师,HLN 的 12 个月平均目标价为 $10.20,最高 $10.20、最低 $10.20。若有图表,中位目标价可在上方查看。相对当前价 $8.98,隐含约 +13.6% 的上行空间。

HLN 目标价HLN 分析师目标价HLN 12个月目标价目标价 HLN

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.